Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

REGENXBIO Inc. (RGNX)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Net income  -280.3127.8-111.3-94.799.9-73.2-63.0-23.8
Depreciation and amortization  12.99.68.47.24.02.70.50.1
Stock-based compensation     26.916.610.67.02.9
Change in working capital   [+]103.0-2.666.243.2-18.826.433.510.4
Other operating activities  -43.184.1-17.4-90.12.9-24.5-26.7-12.1
Cash from operations  -207.5218.9-54.1-107.7104.6-58.0-48.6-22.5
   
Capital expenditures  30.784.226.9-11.7-13.3-7.2-8.1-0.5
Purchases of short-term investments, net  185.4503.7160.099.3625.61.627.5-163.3
Other cash from investing  -228.1-994.6-64.16.0-891.70.80.0 
Cash from investing  -11.9-406.6122.893.6-279.4-4.819.4-163.8
   
Issuance of common stock, net         145.2
Option exercises  2.84.35.67.114.52.50.20.1
Other cash from financing  -26.0199.5205.815.4218.987.10.394.2
Cash from financing  -28.8195.3200.28.4204.484.60.1239.3
   
Free cash flow  -176.8303.1-27.2-119.491.4-65.2-56.7-23.0
        Per share (diluted)  ($4.10)$6.90($0.73)($3.25)$2.49($2.18)($2.15)($2.51)
   
Cash paid for interest         0.0
Cash paid for income taxes  11.86.0-0.20.93.4   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy